Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Lattice Biologics Ltd (LBL.VN)

Lattice Biologics Ltd (LBL.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 5,129
  • Shares Outstanding, K 128,218
  • Annual Sales, $ 2,464 K
  • Annual Income, $ -1,483 K
  • 60-Month Beta -14.66
  • Price/Sales 2.59
  • Price/Cash Flow N/A
  • Price/Book 40.36
Trade LBL.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings $0.00 on N/A
  • Next Earnings Date 03/07/22
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.035 +14.29%
on 05/28/21
0.045 -11.11%
on 05/14/21
-0.005 (-11.11%)
since 05/03/21
3-Month
0.035 +14.29%
on 05/28/21
0.080 -50.00%
on 03/15/21
-0.010 (-20.00%)
since 03/03/21
52-Week
0.025 +60.00%
on 11/26/20
0.130 -69.23%
on 01/19/21
-0.005 (-11.11%)
since 06/03/20

Most Recent Stories

More News
Lattice Biologics Ltd. Reports Second Quarter 2021 Results and Resumes Trading

Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q2 2021.

LBL.VN : 0.040 (unch)
LBLTF : 0.0001 (-99.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic...

See More

Key Turning Points

3rd Resistance Point 0.040
2nd Resistance Point 0.040
1st Resistance Point 0.040
Last Price 0.040
1st Support Level 0.040
2nd Support Level 0.040
3rd Support Level 0.040

See More

52-Week High 0.130
Fibonacci 61.8% 0.090
Fibonacci 50% 0.078
Fibonacci 38.2% 0.065
Last Price 0.040
52-Week Low 0.025

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar